Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2011-08-09
2011-08-09
Wen, Sharon (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S130100, C424S133100, C424S141100
Reexamination Certificate
active
07993646
ABSTRACT:
The invention features hK1 binding polypeptides as well as compositions comprising such polypeptides and methods of making and using such polypeptides.
REFERENCES:
patent: 5215965 (1993-06-01), Lezdey et al.
patent: 5840871 (1998-11-01), Hillman et al.
patent: 6472195 (2002-10-01), Hillman et al.
patent: 2003-252792 (2003-09-01), None
patent: 00/23100 (2000-04-01), None
patent: WO00/23100 (2000-04-01), None
patent: 2004/029238 (2004-04-01), None
patent: WO2004/029238 (2004-04-01), None
patent: 2006/008002 (2006-01-01), None
patent: WO2006/008002 (2006-01-01), None
The Merck Manuals Online Medical Library, [online]. Whitehouse Station, NJ: Merck Research Laboratories, 2006-2007. [retrieved on Nov. 4, 2008]. Retrieved from the Internet: < URL: http://www.merck.com/mmpe/print/sec05/ch048/ch048a.html>. Asthma, pp. 1-15, in particular, see p. 1-2, Etiology.
Pascalis et al. Journal of Immunology 2002, 169:3076-3084.
Vajdos et al. J. Mol. Biol. 2002, 320:415-428.
Padlan et al. PNAS 1989, 86:5938-5942.
Austin, Suzanne, “Drug Discovery Technology Europe 2005—IBC's Ninth Annual Conference and Exhibition”, London, UK, Mar. 15-17, 2005 The Investigational Drugs Journal, 8, (5):370-373.
Bendig, et al., “Humanization of Rodent Monoclonal Antibodies by CDR Grafting”, (1995) Methods, 8:83-93.
Bourgeois et al., “Serpin-derived Peptide Substrates for Investigating the Substrate Specificity of Human Tissue Kallikreins hK1 and hK2*”, (1997) J. Biol. Chemistry 272:29590-29595.
Carmeliet and Jain, “Angiogenesis in cancer and other diseases”, (2000) Nature, 407:249-257.
Casalino-Matsuda et al., “Role of Hyaluronan and Reactive Oxygen Species in Tissue Kallikrein-mediated Epidermal Growth Factor Receptor Activation in Human Airways*”, (2004) J. Biol Chem, 279(20):21606-21616.
Chan et al., “Expression and Characterization of Human Tissue Kallikrein Variants”, (1998) Protein Expr Purif, 12(3): p. 361-370.
Christiansen et al., “Detection of Tissue Kallikrein in the Bronchoalveolar Lavage Fluid of Asthmatic Subjects”, (1987) J. Clin Invest, 79(1):188-197.
Christiansen et al., “Elevation of Tissue Kallikrein and Kinin in the Airways of Asthmatic Subjects after Endobronchial Allergen Challenge”, (1992) Am Rev Respir Dis, 145(4 Pt 1):900-905.
Henderson et al., “The Importance of Leukotrienes in Airway Inflammation in a Mouse Model of Asthma”, (1996) J. Exp Med., 184:1483-1494.
Hoet et al., “Generation of High-Affinity Human Antibodies by Combining Donor-Derived and Synthetic Complementary-Determining-Region Diversity”, (Mar. 2005) Nature Biotechnology, vol. 23 (3):344-348.
Irie et al., “Human Urinary Prokallikrein: Rapid Purification and Model Activation by Trypsin”, (1986) Biochem. Int. 13:375-382.
Kashmiri, et al., “SDR grafting—a new approach to antibody humanization”, (2005) Methods, 36:25-34.
Kizuki et al., “An Inactive Form of Kallikrein in Human Urine”, (1986) Adv Exp Med Biol, 198 (Pt A):329-337.
Lauredo et al., “Leukocytic cell sources of airway tissue kallikrein”, (2004) Am J Physiol Lung Cell Mol Physiol, 286(4): L734-740.
Murthy et al., “Purification and Characterization of Canine Urinary Kallikrein”, (1986) Arch Biochem Biophys, 244 (2):563-571.
Ole-Moiyoi, et al., “Inhibition of Human Urinary Kallikrein (Urokallikrein) by Anti-Enzyme Fab”, (1978) Journal of Immunology, 121:66-71.
Pimenta, et al., “Design of inhibitors for human tissue kallikrein using non-natural aromatic and basic amino acids”, (2002) Biol. Chem., 383:853-857.
Pinkus et al., “Immunohistochemical Localization of Glandular Kallikrein in the Endocrine and Exocrine Human Pancreas”, (1983) The Journal of Histochemistry and Cytochemistry, vol. 31 (11):1279-1288.
Proud et al., “Localization of Immunoreactive Tissue Kallikrein in Human Trachea”, (1993) Am J. Respir Cell Mol Biol, 8 (1):16-19.
Rudikoff, et al., “Single Amino Acid Substitution Altering Antigen-Binding Specificity”, (1982) PNAS, 79:1979-1983.
Savoy-Moore et al., “Characterization of Monoclonal Antibodies Against Rat Glandular Kallikrein”, (1986) Journal of Immunological Methods, 88:45-51.
Sexton et al., “Antibody inhibitors of airway tissue kallikrein 1”,. Immunol. 176, Suppl. S, p. S286 (Apr. 2006) and Ann. Meeting of the Am. Assoc. Immunol. (May 2006).
Silver et al., “Active Site Radioimmunoassay for Human Urokallikrein and Demonstration by Radioimmunoassay of a Latent Form of the Enzyme”, (Apr. 1980) The Journal of Immunology, vol. 124 (4):1551-1555.
Stella et al., “Isolation and Partial Characterization of Rabbit Urinary Kallikrein”, (1989) Adv Exp Med Biol, 247B:195-200.
Takaoka et al., “Purification to Apparent Homogeneity of Inactive Kallikrein from Rat Urine”, (1984) Biochem Biophys Res Commun, 122(3):1282-1288.
Wassaf et al., “High-throughput affinity ranking of antibodies using surface plasmon resonance microarrays,” (Apr. 2006) Anal. Biochem. vol. 351 (2):241-53.
Yousef et al., “The New Human Tissue Kallikrein Gene Family: Structure, Function, and Association to Disease”, (2001) Endocrine Reviews 22:184-204.
International Search Report, the Written Opinion and International Preliminary Report on Patentability for PCT/US2005/027493 dated Sep. 3, 2007.
Irie et al., “Human Urinary Prokallikrein: Rapid Purification and Model Activation by Trypsin”, (1986) Biochem. Int. 13, 375-382.
Kizuki et al., “An Inactive Form of Kallikrein in Human Urine”, (1986) Adv Exp Med Biol, 198 Pt A:329-337.
Austin, Suzanne, “Drug Discovery Technology Europe 2005—IBC's Ninth Annual Conference and Exhibition”, London, UK, Mar. 15-17,The Investigational Drugs Journal, vol. 8, No. 5., pp. 370-373 (2005).
Hoet et al., “Generation of High-Affinity Human Antibodies by Combining Donor-Derived and Synthetic Complementary-Determining-Region Diversity”,Nature Biotechnology, vol. 23,No. 3, pop. 344-348, (Mar. 2005).
Pinkus et al., “Immunohistochemical Localization of Glandular Kallikrein in the Endocrine and Exocrine Human Pancreas”,The Journal of Histochemistry and Cytochemistry, vol. 31, No. 11, pp. 1279-1288, (1983).
Savoy-Moore et al., “Characterization of Monoclonal Antibodies Against Rat Glandular Kallikrein”,Journal of Immunological Methods, 88: pp. 45-51, (1986).
Sexton et al., “Antibody inhibitors of airway tissue kallikrein 1”,J. Immunol. 176, Suppl. S, p. S286 (Apr. 2006) andAnn. Meeting of the Am. Assoc. Immunol. May 2006.
Silver et al., “Active Site Radioimmunoassay for Human Urokallikrein and Demonstration by Radioimmunoassay of a Latent Form of the Enzyme”,The Journal of Immunology, vol. 124, No. 4, pp. 1551-1555, (Apr. 1980).
Wassaf et al., “High-throughput affinity ranking of antibodies using surface plasmon resonance microarrays,”Anal. Biochem. vol. 351 (2):241-53, Apr. 2006.
Rezacova et al., “Inhibition of HIV protease by monoclonal antibodies”, Journal of Molecular Recognition, vol. 15, pp. 272-276, 2002.
Ladner Robert C.
Nixon Andrew
Sexton Daniel J.
Williams Anthony
Wu Qi-Long
Dyax Corp.
Lando & Anastasi LLP
Wen Sharon
LandOfFree
HK1-binding proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HK1-binding proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HK1-binding proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2640725